Novel Agent Cuts Stroke in Hard-to-Treat Afib, University Duisburg-Essen Study Finds

MedPageToday -- LOS ANGELES -- In patients with atrial fibrillation who can’t take vitamin K antagonist therapy, the experimental anticoagulant apixaban is superior to aspirin for preventing stroke or systemic embolism, final results of the AVERROES trial confirmed.